Birdwatch Note
2023-05-02 08:57:49 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
Like many other medications, ivermectin has both human and veterinary uses. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3043740/ Proven uses for ivermectin are all for the treatment of parasites. https://list.essentialmeds.org/medicines/58 https://www.cdc.gov/parasites/onchocerciasis/treatment.html https://www.nps.org.au/radar/articles/ivermectin-stromectol-for-typical-and-crusted-scabies https://www.tga.gov.au/news/media-releases/new-restrictions-prescribing-ivermectin-covid-19 The WHO, CDC, and other organizations encouraged clinical trials for ivermectin in COVID-19 https://www.who.int/news-room/feature-stories/detail/who-advises-that-ivermectin-only-be-used-to-treat-covid-19-within-clinical-trials https://www.clinicaltrials.gov/ct2/results?cond=COVID-19&term=ivermectin&cntry=&state=&city=&dist=&Search=Search there is no evidence it works https://www.cochrane.org/CD015017/INFECTN_ivermectin-preventing-and-treating-covid-19
Written by AFC5C07D009FE4C54C28253564AB95C4ACD4F3E1BB017002587865A55AE6ACDE
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1429050070243192839
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1653322893173063685
- noteId - 1653322893173063685
- participantId -
- noteAuthorParticipantId - AFC5C07D009FE4C54C28253564AB95C4ACD4F3E1BB017002587865A55AE6ACDE Participant Details
- createdAtMillis - 1683017869643
- tweetId - 1429050070243192839
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 1
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Like many other medications, ivermectin has both human and veterinary uses. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3043740/ Proven uses for ivermectin are all for the treatment of parasites. https://list.essentialmeds.org/medicines/58 https://www.cdc.gov/parasites/onchocerciasis/treatment.html https://www.nps.org.au/radar/articles/ivermectin-stromectol-for-typical-and-crusted-scabies https://www.tga.gov.au/news/media-releases/new-restrictions-prescribing-ivermectin-covid-19 The WHO, CDC, and other organizations encouraged clinical trials for ivermectin in COVID-19 https://www.who.int/news-room/feature-stories/detail/who-advises-that-ivermectin-only-be-used-to-treat-covid-19-within-clinical-trials https://www.clinicaltrials.gov/ct2/results?cond=COVID-19&term=ivermectin&cntry=&state=&city=&dist=&Search=Search there is no evidence it works https://www.cochrane.org/CD015017/INFECTN_ivermectin-preventing-and-treating-covid-19
Note Status History
createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
2023-05-02 08:57:49 UTC (1683017869643) |
1969-12-31 23:59:59 UTC (-1) |
2023-05-06 02:42:24 UTC (1683340944665) |
NEEDS_MORE_RATINGS | 1969-12-31 23:59:59 UTC (-1) |
Note Ratings
rated at | rated by | |
2023-05-03 08:26:53 -0500 | Rating Details | |
2023-05-03 08:02:20 -0500 | Rating Details | |
2023-05-03 07:03:04 -0500 | Rating Details | |
2023-05-02 18:45:56 -0500 | Rating Details | |
2023-05-02 18:45:22 -0500 | Rating Details | |
2023-05-02 17:53:18 -0500 | Rating Details | |
2023-05-02 16:15:47 -0500 | Rating Details | |
2023-05-02 14:50:42 -0500 | Rating Details | |
2023-05-02 14:25:28 -0500 | Rating Details | |
2023-05-02 14:05:01 -0500 | Rating Details | |
2023-05-02 14:03:42 -0500 | Rating Details | |
2023-05-02 13:52:59 -0500 | Rating Details | |
2023-05-02 12:47:59 -0500 | Rating Details | |
2023-05-02 12:35:17 -0500 | Rating Details | |
2023-05-02 11:52:22 -0500 | Rating Details | |
2023-05-02 11:25:05 -0500 | Rating Details | |
2023-05-02 11:02:46 -0500 | Rating Details | |
2023-05-02 10:56:59 -0500 | Rating Details | |
2023-05-02 10:50:40 -0500 | Rating Details | |
2023-05-02 10:43:28 -0500 | Rating Details | |
2023-05-02 10:41:40 -0500 | Rating Details | |
2023-05-02 10:29:55 -0500 | Rating Details | |
2023-05-02 10:06:55 -0500 | Rating Details | |
2023-05-02 09:46:57 -0500 | Rating Details | |
2023-05-02 08:58:00 -0500 | Rating Details | |
2023-05-02 08:35:00 -0500 | Rating Details | |
2023-05-02 07:37:05 -0500 | Rating Details | |
2023-05-02 07:36:45 -0500 | Rating Details | |
2023-05-02 07:34:40 -0500 | Rating Details | |
2023-05-02 06:30:38 -0500 | Rating Details | |
2023-05-02 06:29:30 -0500 | Rating Details | |
2023-05-02 06:28:54 -0500 | Rating Details | |
2023-05-02 06:01:50 -0500 | Rating Details | |
2023-05-02 05:24:46 -0500 | Rating Details | |
2023-05-02 05:13:07 -0500 | Rating Details | |
2023-05-02 04:41:18 -0500 | Rating Details | |
2023-05-02 04:31:36 -0500 | Rating Details | |
2023-05-02 04:24:34 -0500 | Rating Details | |
2023-05-02 07:36:45 -0500 | Rating Details | |
2023-05-02 06:28:54 -0500 | Rating Details | |
2023-05-02 10:29:55 -0500 | Rating Details | |
2023-05-02 12:35:17 -0500 | Rating Details | |
2023-05-02 10:06:55 -0500 | Rating Details | |
2023-05-03 08:26:53 -0500 | Rating Details | |
2023-05-02 14:25:28 -0500 | Rating Details | |
2023-05-02 14:50:42 -0500 | Rating Details | |
2023-05-02 12:47:59 -0500 | Rating Details | |
2023-05-02 16:15:47 -0500 | Rating Details | |
2023-05-02 04:41:18 -0500 | Rating Details | |
2023-05-02 10:50:40 -0500 | Rating Details | |
2023-05-02 10:41:40 -0500 | Rating Details | |
2023-05-02 08:35:00 -0500 | Rating Details | |
2023-05-02 05:13:07 -0500 | Rating Details | |
2023-05-02 06:30:38 -0500 | Rating Details | |
2023-05-02 11:25:05 -0500 | Rating Details | |
2023-05-02 05:24:46 -0500 | Rating Details | |
2023-05-02 13:52:59 -0500 | Rating Details | |
2023-05-02 18:45:22 -0500 | Rating Details | |
2023-05-02 14:05:01 -0500 | Rating Details | |
2023-05-02 04:31:36 -0500 | Rating Details | |
2023-05-02 18:45:56 -0500 | Rating Details | |
2023-05-02 10:43:28 -0500 | Rating Details | |
2023-05-02 06:29:30 -0500 | Rating Details | |
2023-05-02 10:56:59 -0500 | Rating Details | |
2023-05-02 07:34:40 -0500 | Rating Details | |
2023-05-03 08:02:20 -0500 | Rating Details | |
2023-05-02 07:37:05 -0500 | Rating Details | |
2023-05-02 08:58:00 -0500 | Rating Details | |
2023-05-02 04:24:34 -0500 | Rating Details | |
2023-05-02 17:53:18 -0500 | Rating Details | |
2023-05-03 07:03:04 -0500 | Rating Details | |
2023-05-02 11:52:22 -0500 | Rating Details | |
2023-05-02 11:02:46 -0500 | Rating Details | |
2023-05-02 06:01:50 -0500 | Rating Details | |
2023-05-02 14:03:42 -0500 | Rating Details | |
2023-05-02 09:46:57 -0500 | Rating Details | |
2023-05-22 09:29:51 -0500 | Rating Details | |
2023-05-22 18:18:58 -0500 | Rating Details | |
2023-06-06 10:51:54 -0500 | Rating Details | |
2023-06-07 19:54:33 -0500 | Rating Details | |
2023-06-25 08:40:37 -0500 | Rating Details | |
2023-07-26 10:31:43 -0500 | Rating Details | |
2023-08-08 08:24:10 -0500 | Rating Details | |
2023-08-11 18:08:20 -0500 | Rating Details | |
2023-08-11 09:26:33 -0500 | Rating Details | |
2023-08-11 06:56:20 -0500 | Rating Details | |
2023-08-13 16:15:19 -0500 | Rating Details | |
2023-08-13 11:43:46 -0500 | Rating Details | |
2023-08-13 10:58:00 -0500 | Rating Details | |
2023-08-13 08:47:13 -0500 | Rating Details | |
2023-08-13 07:44:06 -0500 | Rating Details | |
2023-08-13 07:16:41 -0500 | Rating Details | |
2023-08-13 06:39:31 -0500 | Rating Details | |
2023-08-13 04:28:22 -0500 | Rating Details | |
2023-08-13 03:08:13 -0500 | Rating Details | |
2023-08-13 02:06:26 -0500 | Rating Details | |
2023-08-13 00:34:57 -0500 | Rating Details | |
2023-08-12 23:15:43 -0500 | Rating Details | |
2023-08-12 22:35:22 -0500 | Rating Details | |
2023-08-12 20:40:03 -0500 | Rating Details | |
2023-08-12 20:13:07 -0500 | Rating Details | |
2023-08-12 19:47:59 -0500 | Rating Details | |
2023-08-12 19:21:18 -0500 | Rating Details | |
2023-08-12 18:56:01 -0500 | Rating Details | |
2023-08-12 16:31:57 -0500 | Rating Details | |
2023-08-12 16:24:05 -0500 | Rating Details | |
2023-08-12 16:00:11 -0500 | Rating Details | |
2023-08-12 15:39:51 -0500 | Rating Details | |
2023-08-12 15:35:52 -0500 | Rating Details | |
2023-08-12 14:34:55 -0500 | Rating Details | |
2023-08-12 14:05:36 -0500 | Rating Details | |
2023-08-12 13:48:18 -0500 | Rating Details | |
2023-08-12 08:27:43 -0500 | Rating Details | |
2023-08-12 07:37:13 -0500 | Rating Details | |
2023-08-12 07:07:03 -0500 | Rating Details | |
2023-08-11 19:48:38 -0500 | Rating Details | |
2023-08-14 06:59:36 -0500 | Rating Details | |
2023-08-14 00:00:41 -0500 | Rating Details | |
2023-08-13 23:24:07 -0500 | Rating Details | |
2023-08-13 22:34:16 -0500 | Rating Details | |
2023-08-15 13:12:20 -0500 | Rating Details | |
2023-08-15 13:07:18 -0500 | Rating Details | |
2023-08-15 12:29:01 -0500 | Rating Details | |
2023-08-15 11:35:18 -0500 | Rating Details | |
2023-08-16 18:03:40 -0500 | Rating Details | |
2023-08-16 17:57:45 -0500 | Rating Details | |
2023-08-16 13:23:35 -0500 | Rating Details | |
2023-08-17 08:54:17 -0500 | Rating Details | |
2023-08-21 01:20:24 -0500 | Rating Details | |
2023-08-17 09:48:53 -0500 | Rating Details | |
2023-08-16 17:57:42 -0500 | Rating Details | |
2023-08-15 20:42:24 -0500 | Rating Details | |
2023-08-15 18:39:07 -0500 | Rating Details | |
2023-08-14 21:59:59 -0500 | Rating Details | |
2023-08-13 11:32:16 -0500 | Rating Details | |
2023-08-13 11:19:03 -0500 | Rating Details | |
2023-08-13 11:08:00 -0500 | Rating Details | |
2023-08-12 22:58:32 -0500 | Rating Details | |
2023-08-12 18:57:32 -0500 | Rating Details | |
2023-08-12 15:24:41 -0500 | Rating Details | |
2023-08-12 09:17:17 -0500 | Rating Details | |
2023-10-15 07:10:09 -0500 | Rating Details | |
2023-12-03 20:09:34 -0600 | Rating Details | |
2023-12-03 08:52:52 -0600 | Rating Details | |
2024-02-11 08:52:15 -0600 | Rating Details | |
2024-03-08 17:32:26 -0600 | Rating Details | |
2024-03-09 19:52:51 -0600 | Rating Details | |
2024-03-22 22:26:50 -0500 | Rating Details | |
2024-03-22 21:27:29 -0500 | Rating Details | |
2024-03-22 21:25:31 -0500 | Rating Details | |
2024-03-22 19:52:17 -0500 | Rating Details | |
2024-03-22 19:27:44 -0500 | Rating Details | |
2024-03-22 17:36:02 -0500 | Rating Details | |
2024-03-22 04:34:56 -0500 | Rating Details | |
2024-03-23 18:17:00 -0500 | Rating Details | |
2024-03-23 15:02:09 -0500 | Rating Details | |
2024-03-23 07:52:45 -0500 | Rating Details | |
2024-03-23 02:57:06 -0500 | Rating Details | |
2024-03-23 02:33:12 -0500 | Rating Details | |
2024-03-22 22:33:16 -0500 | Rating Details | |
2024-03-23 21:33:14 -0500 | Rating Details | |
2024-03-23 16:55:26 -0500 | Rating Details | |
2024-03-23 14:44:05 -0500 | Rating Details | |
2024-03-23 11:27:37 -0500 | Rating Details | |
2024-03-23 10:50:45 -0500 | Rating Details | |
2024-03-23 08:30:21 -0500 | Rating Details | |
2024-03-23 05:25:49 -0500 | Rating Details | |
2024-03-23 01:50:01 -0500 | Rating Details | |
2024-03-22 19:07:56 -0500 | Rating Details | |
2024-03-22 18:17:09 -0500 | Rating Details | |
2024-03-22 17:58:43 -0500 | Rating Details | |
2024-03-22 17:43:34 -0500 | Rating Details | |
2024-03-22 14:19:42 -0500 | Rating Details | |
2024-03-22 13:57:15 -0500 | Rating Details | |
2024-03-22 13:31:12 -0500 | Rating Details | |
2024-03-22 06:52:23 -0500 | Rating Details | |
2024-03-22 02:13:07 -0500 | Rating Details | |
2024-03-22 00:40:38 -0500 | Rating Details | |
2024-03-14 08:14:01 -0500 | Rating Details | |
2024-03-23 06:39:17 -0500 | Rating Details | |
2024-03-23 06:22:05 -0500 | Rating Details | |
2024-03-23 05:34:23 -0500 | Rating Details | |
2024-03-23 00:20:21 -0500 | Rating Details | |
2024-03-22 23:15:41 -0500 | Rating Details | |
2024-03-22 19:37:25 -0500 | Rating Details | |
2024-03-22 19:21:54 -0500 | Rating Details | |
2024-03-22 18:37:48 -0500 | Rating Details | |
2024-03-22 18:27:55 -0500 | Rating Details | |
2024-03-22 18:16:06 -0500 | Rating Details | |
2024-03-22 17:57:21 -0500 | Rating Details | |
2024-03-22 17:54:24 -0500 | Rating Details | |
2024-03-22 17:37:13 -0500 | Rating Details | |
2024-03-22 15:18:33 -0500 | Rating Details | |
2024-03-22 02:35:07 -0500 | Rating Details | |
2024-03-22 01:48:19 -0500 | Rating Details | |
2024-03-22 01:47:55 -0500 | Rating Details | |
2024-03-28 13:34:11 -0500 | Rating Details | |
2024-03-31 18:50:19 -0500 | Rating Details | |
2024-03-31 16:36:00 -0500 | Rating Details | |
2024-04-01 21:14:59 -0500 | Rating Details | |
2024-04-02 02:06:13 -0500 | Rating Details | |
2024-04-01 16:12:38 -0500 | Rating Details | |
2024-04-01 11:28:39 -0500 | Rating Details | |
2024-04-01 10:51:11 -0500 | Rating Details |